4Dler Besarani D C. Urological malignancy after renal transplantation[J]. BJU International, 2007,100(3): 502--505.
5Huang P C, Huang C Y, Huang S W, etal. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan[J]. Int J Urol, 2006,13(7): 864-869.
6Kauffman H M,Cherikh W S, McBride M A, et al. Post transplant de novo malignancies in renal transplant recipients: the past and present[J]. Transpl Int, 2006, 19(8) : 607--620.
7Hung Y M, Chou K J, Hung S Y. De novo malignan cies after kidney transplantation[J]. Urology, 2007,69 (6): 1041-1044.
8Marcen R, Pascual J, Tato A M, et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation[J].Transplant Proc, 2003, 35 (5): 1714--1716.
9Li X B , Xing N Z, Wang Y, et al. Transitional cell carcinoma in renal transplant recipients: a single center experience[J]. Int J Urol, 2008,15(1): 53-57.
6Vegso G,Toth M,Hidvegi M,et al.Malig nancies af ter renal transplantation during 33 years at a single center[J].Pathol Oncol Res,2007,13(1):63-69.
7Kasiske BL,Snyder JJ,Gilbertson DT,et al.Cancer after kidneytransplantation in the United States[J].Am J Transplant,2004,4(6):905–913.
8Suthanthiran M,Hojo M,Maluccio M,et a1.Post—transplantation malignancy:a cell autonomous mechanism with implications for therapy[J].Trans Am Clin Climatol Assoc,2009,120:369-388.
9Horacek JM,Pudil R,Tichy M,et al.Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia[J].Exp Oncol,2007,29(3):243-247.
